Petersen Jeffrey, Jhala Darshana
Department of Pathology and Laboratory Medicine, Michael J. Crescenz Veteran Affairs, Medical Center, 3900 Woodland Avenue, Philadelphia, PA 19104, United States.
University of Pennsylvania Perelman School of Medicine, United States.
Pract Lab Med. 2018 May 7;12:e00100. doi: 10.1016/j.plabm.2018.e00100. eCollection 2018 Nov.
Anti-A antibodies can be found as a usually clinically insignificant naturally occurring cold IgM antibody in A-subgroup patients. It is known from multiple prior case reports that warm-reactive anti-A that reacts at 37 °C can be clinically significant, and it has been previously reported that it could form after alloimmunization with donor A red blood cell (RBC) transfusion. In addition, the development of anti-A, often as an autoantibody, have been described in the setting of various malignancies, perhaps due to expressed subtle alterations of the ABO antigens provoking an immune response. Here, we report a rare case of a cold-reactive anti-A alloantibody (after multiple transfusions with group A RBC units) in a 76 year old male patient (A) with history of myelodysplastic syndrome and metastatic carcinoma who presented with hemolytic anemia and dark urine. The patient had previously typed as blood type A without reverse typing reaction for anti-A; as a result, the patient had been transfused with group A RBCs. Four days prior to discovery of the ABO discrepancy, the patient had a febrile transfusion reaction associated with his A RBC transfusion. On admission, his immunohematology workup demonstrated an alloantibody to anti-A that coincidentally appeared during a new onset of hemolytic anemia. Case reports of patients with hemolytic anemia with a newly developed anti-A alloantibody are sparse in the literature, and this case is particularly interesting as the cold reactive anti-A (without demonstrable wide thermal amplitude) appeared to form after alloimmunization and in the setting of an underlying malignancy.
在A亚群患者中,抗A抗体通常可作为临床上无显著意义的天然存在的冷IgM抗体被发现。从多个既往病例报告可知,在37°C反应的温反应性抗A抗体可能具有临床意义,并且此前有报道称,它可在接受供体A红细胞(RBC)输血后发生同种免疫后形成。此外,抗A抗体(常作为自身抗体)的产生已在各种恶性肿瘤背景下被描述,这可能是由于ABO抗原的细微改变引发了免疫反应。在此,我们报告一例罕见病例,一名76岁男性患者(血型为A)有骨髓增生异常综合征和转移性癌病史,在多次输注A型RBC单位后出现了冷反应性抗A同种抗体,该患者表现为溶血性贫血和深色尿。该患者之前血型鉴定为A型,抗A反向定型无反应;因此,该患者接受了A型RBC输血。在发现ABO血型不符的四天前,该患者在输注A型RBC时发生了发热性输血反应。入院时,他的免疫血液学检查显示存在抗A同种抗体,该抗体在溶血性贫血新发时巧合出现。文献中溶血性贫血伴新出现抗A同种抗体患者的病例报告较少,该病例尤其有趣,因为冷反应性抗A(无明显宽热幅度)似乎在同种免疫后且在潜在恶性肿瘤背景下形成。